XML 13 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue $ 1,272,689 $ 800,007 $ 4,532,274 $ 4,892,802
Costs of sales 1,189,172 787,078 4,145,008 4,828,647
Gross margin 83,517 12,929 387,266 64,155
Operating expenses:        
Product development, quality management and excess production capacity 507,466 320,137 1,076,881 883,979
Marketing and sales 202,106 362,851 703,201 749,913
General and administrative 732,427 581,561 2,216,656 2,788,381
Total operating costs and expenses 1,441,999 1,264,549 3,996,738 4,422,273
Loss from operations (1,358,482) (1,251,620) (3,609,472) (4,358,118)
Other (income) expense:        
Interest expense 190,318 108,395 542,970 241,944
Amortization of debt discount 132,497 0 414,525 373,553
Change in fair value of derivative liabilities (730,000) (445,684) (253,935) (919,361)
Total other income (407,185) (337,289) 703,560 (303,864)
Net loss (951,297) (914,331) (4,313,032) (4,054,254)
Accretion of preferred stock dividends and beneficial conversion feature (405,936) (438,922) (1,218,273) (1,262,126)
Net loss attributable to common shareholders $ (1,357,233) $ (1,353,253) $ (5,531,305) $ (5,316,380)
Weighted average common shares - basic and diluted 30,307,925 26,766,317 29,583,289 26,157,795
Net loss per share - basic and diluted $ (0.04) $ (0.05) $ (0.19) $ (0.20)